Key facts
- Corify Care’s last known valuation is $8.3M (Jul 2021).
- It has raised $7.1M; the latest was Later Stage VC ($3.1M) in Jan 2025.
- Notable investors include INNVIERTE SICC, Clave (Pamplona), CaixaBank, Capital Cell, EIT Health — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Corify Care
- ·The full record, as it builds
Funding rounds
No funding rounds for Corify Care are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Corify Care
Developer of a medical technology designed to improve the treatment of atrial fibrillation. The company develops a medical device that can see the electrical activity of the heart without the need for any surgery or complex computed tomography and magnetic resonance imaging mappings and improve the clinical management of cardiac arrhythmias, enabling healthcare professionals to see the atrial activity during each diagnosis procedure and identify its origin.
- Sector
- Healthcare
- HQ
- Madrid, Spain
- Founded
- 2019
- Employees
- 30
- Website
- corify.es/
- Ownership
- Privately Held (backing)
Corify Care doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Corify Care shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Corify Care in its N-PORT filings yet. We sweep new filings monthly.